For most people with chronic hepatitis C, treatment with direct-acting antiviral (DAA) therapy is simple and easily incorporated into primary care. GPs can help in the push to eliminate hepatitis C by 2030 through strategies to eliminate hepatitis C from their own practices. This includes finding their patients with hepatitis C, assessing, treating and following up after DAA therapy.
- GPs can help achieve the goal of eliminating hepatitis C in Australia by 2030 through ‘microelimination’ in their own practices.
- Since 2016, over 6000 Australian GPs have treated patients with direct-acting antiviral (DAA) therapy.
- For most people with chronic hepatitis C, treatment with DAA therapy is simple and easily incorporated into primary care.
- Patients can be tested for hepatitis C, assessed, treated and followed up for cure in four GP visits, with an optional fifth visit during treatment.
- Ongoing care for patients after DAA therapy includes care of comorbidities and strategies to prevent and detect reinfection in those with ongoing risk.